0.1303 USD
-0.0006
0.46%
At close Oct 9, 4:00 PM EDT
Pre-market
0.1302
-0.0001
0.08%
1 day
-0.46%
5 days
-4.19%
1 month
1.88%
3 months
-9.45%
6 months
-7.39%
Year to date
-29.80%
1 year
-23.08%
5 years
-60.91%
 

About: Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.

Employees: 144

0
Funds holding %
of 6,740 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

0.03% less ownership

Funds ownership: 8.89% [Q1] → 8.86% (-0.03%) [Q2]

0% less capital invested

Capital invested by funds: $12.3M [Q1] → $12.3M (-$12.8K) [Q2]

6% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 16

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

1% less funds holding

Funds holding: 96 [Q1] → 95 (-1) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for ZOM.

Financial journalist opinion

Charts implemented using Lightweight Charts™